Schrodinger (NASDAQ:SDGR) Lowered to “Strong Sell” Rating by Wall Street Zen

Wall Street Zen lowered shares of Schrodinger (NASDAQ:SDGR) from a hold rating to a strong sell rating in a research note released on Saturday.

Several other equities analysts have also commented on the stock. KeyCorp dropped their price target on shares of Schrodinger from $25.00 to $20.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. UBS Group dropped their price target on shares of Schrodinger from $18.00 to $13.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 17th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Schrodinger in a research note on Friday, January 9th. Four investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $20.50.

Schrodinger Price Performance

SDGR stock opened at $13.13 on Friday. The firm has a market capitalization of $969.26 million, a P/E ratio of -9.31 and a beta of 1.57. The business’s 50-day moving average is $12.09 and its two-hundred day moving average is $15.31. Schrodinger has a 1 year low of $10.94 and a 1 year high of $27.63.

Schrodinger (NASDAQ:SDGR) last released its quarterly earnings data on Tuesday, May 5th. The company reported ($0.81) EPS for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.25). The business had revenue of $58.59 million during the quarter, compared to analysts’ expectations of $47.57 million. Schrodinger had a negative net margin of 40.61% and a negative return on equity of 30.85%. The company’s revenue was down 1.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.82) EPS. On average, analysts expect that Schrodinger will post -1.26 EPS for the current year.

Insider Transactions at Schrodinger

In related news, CEO Ramy Farid sold 43,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $12.33, for a total transaction of $530,190.00. Following the transaction, the chief executive officer owned 330,824 shares in the company, valued at $4,079,059.92. This trade represents a 11.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 59,184 shares of company stock worth $741,556. Company insiders own 21.00% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in SDGR. EverSource Wealth Advisors LLC grew its stake in Schrodinger by 722.8% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,374 shares of the company’s stock worth $25,000 after buying an additional 1,207 shares during the last quarter. Los Angeles Capital Management LLC purchased a new position in Schrodinger during the 4th quarter worth approximately $26,000. Hantz Financial Services Inc. grew its stake in Schrodinger by 5,025.8% during the 4th quarter. Hantz Financial Services Inc. now owns 1,589 shares of the company’s stock worth $28,000 after buying an additional 1,558 shares during the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new position in Schrodinger during the 4th quarter worth approximately $36,000. Finally, Aster Capital Management DIFC Ltd grew its stake in Schrodinger by 212.4% during the 3rd quarter. Aster Capital Management DIFC Ltd now owns 1,943 shares of the company’s stock worth $39,000 after buying an additional 1,321 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.